Parviz Vahedi

Prof. Parviz Vahedi


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
LCLeila Chodari
Leila Chodari
MAMutlu Dilsiz Aytemir
Mutlu Dilsiz Aytemir
PVParviz Vahedi
Parviz Vahedi
MAMahdieh Alipour
Mahdieh Alipour
SVSepideh Zununi Vahed
Sepideh Zununi Vahed
EAEftekhari Aziz
Eftekhari Aziz
Appropriate mitochondrial physiology is an essential for health and survival. Cells have developed unique mechanisms to adapt to stress circumstances and changes in metabolic demands, by meditating mitochondrial function and number. In this context, sufficient mitochondrial biogenesis is necessary for efficient cell function and haemostasis, which is dependent on the regulation of ATP generation and maintenance of mitochondrial DNA (mtDNA). These procedures play a primary role in the processes of inflammation, aging, cancer, metabolic diseases, and neurodegeneration. Polyphenols have been considered as the main components of plants, fruits, and natural extracts with proven therapeutic effects during the time. These components regulate the intracellular pathways of mitochondrial biogenesis. Therefore, the current review is aimed at representing an updated review which determines the effects of different natural polyphenol compounds from various plant kingdoms on modulating signaling pathways of mitochondrial biogenesis that could be a promising alternative for the treatment of several disorders.

1 January 2023 in Nanotheranostics
Verified
Journal Article
Open access
PDF file
EAElham Ahmadian
Elham Ahmadian
EAEftekhari Aziz
Eftekhari Aziz
Dawid JanasDawid Janas
Dawid Janas
PVParviz Vahedi
Parviz Vahedi
Articular cartilage has a low self-repair capacity due to the lack of vessels and nerves. In recent times, nanofiber scaffolds have been widely used for this purpose. The optimum nanofiber scaffold should stimulate new tissue's growth and mimic the articular cartilage nature. Furthermore, the characteristics of the scaffold should match those of the cellular matrix components of the native tissue to best merge with the target tissue. Therefore, selective modification of prefabricated scaffolds based on the structure of the repaired tissues is commonly conducted to promote restoring the tissue. A thorough analysis is required to find out the architectural features of scaffolds that are essential to make the treatment successful. The current review aims to target this challenge. The article highlights different optimization approaches of nanofibrous scaffolds for improved cartilage tissue engineering. In this context, the influence of the architecture of nanoscaffolds on performance is discussed in detail. Finally, based on the gathered information, a future outlook is provided to catalyze development in this promising field.

25 September 2019 in Drug Research
Verified
Journal Article
Closed access
PDF file
EAElham Ahmadian
Elham Ahmadian
SMSolmaz Maleki
Solmaz Maleki
AEAziz Eftekhari
Aziz Eftekhari
EAElaheh Dalir Abdolahinia
Elaheh Dalir Abdolahinia
PVParviz Vahedi
Parviz Vahedi
MSMohammad Samiei
Mohammad Samiei
Hyaluronic acid (HA) is widely used in the biomedicine due to its biocompatibility, biodegradability, and nontoxic properties. It is crucial for cell signaling role during morphogenesis, inflammation, and wound repair. After hydrogel formation, HA easily is converted to elastic sheets in order to use in preclinical and clinical applications. In addition, HA-derived hydrogels are easily used as vectors for cell and medication in tissue repairing and regenerative medicine. Moreover, in comparison with other polymers, HA -based hydrogels play a key role in in cellular behavior, including stem cell differentiation. The current paper reviews both basic concepts and recent advances in the development of HA-based hydrogels for biomedical applications.

Verified
Journal Article
Open access
PDF file
PVParviz Vahedi
Parviz Vahedi
RMRana Moghaddamshahabi
Rana Moghaddamshahabi
TWThomas Webster
Thomas Webster
ACAyse Ceren Calikoglu-Koyuncu
Ayse Ceren Calikoglu-Koyuncu
EAElham Ahmadian
Elham Ahmadian
EAEftekhari Aziz
Eftekhari Aziz
Cartilage is frequently damaged with a limited capacity for repair. Current treatment strategies are insufficient as they form fibrocartilage as opposed to hyaline cartilage, and do not prevent the progression of degenerative changes. There is increasing interest in the use of autologous mesenchymal stem cells (MSC) for tissue regeneration. MSCs that are used to treat articular cartilage defects must not only present a robust cartilaginous production capacity, but they also must not cause morbidity at the harvest site. In addition, they should be easy to isolate from the tissue and expand in culture without terminal differentiation. The source of MSCs is one of the most important factors that may affect treatment. The infrapatellar fat pad (IPFP) acts as an important reservoir for MSC and is located in the anterior compartment of the knee joint in the extra-synovial area. The IPFP is a rich source of MSCs, and in this review, we discuss studies that demonstrate that these cells have shown many advantages over other tissues in terms of ease of isolation, expansion, and chondrogenic differentiation. Future studies in articular cartilage repair strategies and suitable extraction as well as cell culture methods will extend the therapeutical application of IPFP-derived MSCs into additional orthopedic fields, such as osteoarthritis. This review provides the latest research concerning the use of IPFP-derived MSCs in the treatment of articular cartilage damage, providing critical information for the field to grow.

Verified
Journal Article
Open access
PDF file
OKomid kooshkaki
omid kooshkaki
ZRZohreh Rezaei
Zohreh Rezaei
MRMeysam Rahmati
Meysam Rahmati
PVParviz Vahedi
Parviz Vahedi
ADAfshin Derakhshani
Afshin Derakhshani
Behzad BaradaranBehzad Baradaran
Behzad Baradaran
MicroRNAs (miRNAs) are small and non-coding RNAs that display aberrant expression in the tissue and plasma of cancer patients when tested in comparison to healthy individuals. In past decades, research data proposed that miRNAs could be diagnostic and prognostic biomarkers in cancer patients. It has been confirmed that miRNAs can act either as oncogenes by silencing tumor inhibitors or as tumor suppressors by targeting oncoproteins. MiR-144s are located in the chromosomal region 17q11.2, which is subject to significant damage in many types of cancers. In this review, we assess the involvement of miR-144s in several cancer types by illustrating the possible target genes that are related to each cancer, and we also briefly describe the clinical applications of miR-144s as a diagnostic and prognostic tool in cancers.

24 December 2019 in BioFactors
Verified
Journal Article
Closed access
PDF file
SHSaeed Mohammadian Haftcheshmeh
Saeed Mohammadian Haftcheshmeh
MKMohammad R. Karimzadeh
Mohammad R. Karimzadeh
SASara Azhdari
Sara Azhdari
PVParviz Vahedi
Parviz Vahedi
EAElham Abdollahi
Elham Abdollahi
AMAmir Abbas Momtazi-Borojeni
Amir Abbas Momtazi-Borojeni